1. Home
  2. CKX vs MRKR Comparison

CKX vs MRKR Comparison

Compare CKX & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

N/A

Current Price

$10.45

Market Cap

19.5M

Sector

Energy

ML Signal

N/A

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.27

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CKX
MRKR
Founded
1930
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
16.6M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CKX
MRKR
Price
$10.45
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.25
AVG Volume (30 Days)
2.8K
269.7K
Earning Date
11-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
2.14
N/A
EPS
0.23
N/A
Revenue
$897,333.00
$4,694,988.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.06
P/E Ratio
$42.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.66
$0.81
52 Week High
$14.00
$5.95

Technical Indicators

Market Signals
Indicator
CKX
MRKR
Relative Strength Index (RSI) 51.29 66.06
Support Level $8.66 $1.15
Resistance Level $10.39 $1.27
Average True Range (ATR) 0.33 0.10
MACD -0.01 0.03
Stochastic Oscillator 80.80 95.26

Price Performance

Historical Comparison
CKX
MRKR

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: